Prequalification Update - 28 November 2011

WHO Prequalification Programme adds the below new products to its prequalified list

• HA416:    Nelfinavir (as mesylate) - 250mg - Tablets - Cipla Ltd - INDIA

• HA505:    Abacavir (as sulfate)/Lamivudine/Zidovudine - 300mg/150mg/300mg - Tablets -
                  Matrix Laboratories Ltd - INDIA

• HA507:    Atazanavir (as sulfate)/Ritonavir - 300mg/100mg - Tablets - Matrix Laboratories Ltd - INDIA

• HA512:    Tenofovir disoproxil fumarate/Lamivudine+Atazanavir (as sulfate)+Ritonavir -
                  300mg/300mg+300mg+100mg - Tablets+Capsules+Tablets - Matrix Laboratories Ltd - INDIA

Related Link:  WHO List of Prequalified Medicinal Products